<DOC>
	<DOC>NCT00298701</DOC>
	<brief_summary>This trial is performed to assess whether the Grazax-R treatment is safe to use in children aged 5-12 years.</brief_summary>
	<brief_title>Tolerability of Grazax-R in Children</brief_title>
	<detailed_description />
	<criteria>Grass pollen induced rhinoconjunctivitis Boys and girls, 512 years of age Positive skin prick test to grass pollen Previous treatment with immunotherapy</criteria>
	<gender>All</gender>
	<minimum_age>5 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>May 2006</verification_date>
	<keyword>Allergy</keyword>
</DOC>